XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.20.2

STOCK-BASED COMPENSATION PLANS | 6 Months Ended
--- | ---
Jun. 30, 2020
STOCK-BASED COMPENSATION PLANS |
STOCK-BASED COMPENSATION PLANS | (4) STOCK-BASED COMPENSATION PLANS In June 2017, our stockholders approved the 2017 Stock Incentive Plan (the “2017 Stock Plan”) with a maximum of 5,000,000 shares reserved for issuance. Awards permitted under the 2017 Stock Plan include: Stock Options and Restricted Stock. Awards issued under the 2017 Stock Plan are at the discretion of the Board of Directors. As applicable, awards are granted with an exercise price equal to the closing price of our common stock on the date of grant and generally vest over four years. Restricted Stock Awards are issued to the recipient upon grant and are not included in outstanding shares until such vesting and issuance occurs. During the three months ended June 30, 2020, no stock option awards were granted under the 2017 Stock Plan. During the six months ended June 30, 2020, 14,000 stock option awards were granted under the 2017 Stock Plan. During the three and six months ended June 30, 2019, 35,000 and 0.4 million stock option awards were granted under the 2017 Stock Plan, respectively. At June 30, 2020, the company had 1.2 million stock options outstanding and 0.6 million exercisable under the following plans: ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | Outstanding |  | Exercisable
​ | ​ | Number of Options | ​ | Number of Options
​ | ​ | (in thousands) | ​ | (in thousands)
Plan Category |  |  |  | ​ |
2005 Stock Option Plan |  | 384 |  | ​ | 384
Equity Compensation Plans not approved by Shareholders |  | 60 |  | ​ | 45
2017 Stock Option Plan |  | 709 |  | ​ | 164
Total |  | 1,153 | ​ | $ | 593
​ During the three and six months ended June 30, 2020, 38,000 and 208,000 shares of restricted stock were granted to the Board of Directors and management under the 2017 Stock Plan, respectively. During the three and six months ended June 30, 2019, 5,000 and 10,000 shares of restricted stock were granted, respectively. The fair market value of restricted shares for share-based compensation expensing is equal to the closing price of our common stock on the date of grant. The vesting on the Restricted Stock Awards typically occur quarterly over three years for the Board of Directors and quarterly or annually over two to four years for management. The following summarizes stock-based compensation expenses recorded in the consolidated statements of operations: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended June 30, | ​ | For the Six Months Ended June 30,
​ |  | 2020 |  | 2019 |  | 2020 |  | 2019
Cost of Revenue | ​ | $ | 2 | ​ | $ | 5 | ​ | $ | 9 | ​ | $ | 10
Sales and marketing expense | ​ |  | 98 | ​ |  | 52 | ​ |  | 127 | ​ |  | 94
General, and administrative | ​ |  | 479 | ​ |  | 101 | ​ |  | 940 | ​ |  | 194
Total stock based compensation expense | ​ | ​ | 579 | ​ | ​ | 158 | ​ | ​ | 1,076 | ​ | ​ | 298
​ During the six months ended June 30, 2020, there were 14,000 options granted at a weighted average exercise price of $10.15 per share. The weighted-average grant date fair value of options granted during the six months ended June 30, 2020 was $8.88. There were no options granted during the three months ended June 30, 2020. The Company issued 38,000 and 208,000 shares of restricted stock to management during the three and six months ended June 30, 2020, respectively. During the six months ended June 30, 2019, there were 415,000 options granted at a weighted average price exercise price of $4.53 per share. The weighted-average grant date fair value of options granted during the six months ended June 30, 2019 was $4.01. The Company issued 10,000 shares of restricted stock to management during the six months ended June 30, 2019. The Company received proceeds of $0.1 million and $0.3 million related to option exercises during the three and six months ended June 30, 2020, respectively. The Company received proceeds of approximately $0.1 million related to option exercises during both the three and six months ended June 30, 2019. The Company used the Black Scholes option pricing model to determine the fair value of stock option grants, using the following assumptions for the three and six months ended June 30, 2020 and June 30, 2019. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months |  | For the Six Months |
​ | ​ | Ended June 30, |  | Ended June 30, |
​ |  | 2020 | ​ | 2019 |  | 2020 | ​ | 2019 |
Expected term (years) | ​ | — | ​ | 6.25 | ​ | 6.79 | ​ | 6.25 | ​
Risk-free interest rate | ​ | — | % | 2.49 | % | 1.59 | % | 2.59 | %
Expected volatility | ​ | — | % | 121.49 | % | 116.76 | % | 121.95 | %
Expected dividend yield | ​ | — | % | — | % | — | % | — | %
​ A summary of stock option activity under all equity compensation plans for the six months ended June 30, 2020, is presented below: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted- | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Average | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted- | ​ | Remaining | ​ | Aggregate
​ | ​ | Number of | ​ | Average | ​ | Contractual | ​ | Intrinsic
​ | ​ | Shares | ​ | Exercise | ​ | Term | ​ | Value
​ |  | (in thousands) |  | Price |  | (Years) |  | (in thousands)
Outstanding at December 31, 2019 | ​ | 1,855 | ​ | $ | 2.48 | ​ | 6.42 | ​ | $ | 10,032
Granted | ​ | 14 | ​ | $ | 10.15 | ​ | — | ​ |  | —
Expired | ​ | — | ​ | ​ | — | ​ | — | ​ | ​ | —
Forfeited | ​ | (206) | ​ | $ | 5.10 | ​ | — | ​ |  | —
Exercised | ​ | (510) | ​ | $ | 0.99 | ​ | — | ​ |  | —
Outstanding at June 30, 2020 | ​ | 1,153 | ​ | $ | 2.77 | ​ | 6.79 | ​ | $ | 25,497
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Exercisable at June 30, 2020 | ​ | 593 | ​ | $ | 0.70 | ​ | 5.30 | ​ | $ | 14,341
​ A summary of restricted stock award activity under all equity compensation plans for the six months ended June 30, 2020, is presented below: ​
​ | ​ | ​
​ | ​ | Number of
​ | ​ | Shares
​ |  | (in thousands)
Granted but not vested at December 31, 2019 | ​ | 102
Granted | ​ | 208
Forfeited | ​ | —
Vested | ​ | (49)
Granted but not vested at June 30, 2020 | ​ | 261
​ As of June 30, 2020, the Company had approximately $3.9 million of unrecognized compensation expense related to stock options and restricted stock awards that will be recognized over a weighted average period of approximately 2.4 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration